Abstract:BACKGROUND: Dysregulated metabolism of bioactive sphingolipids, including ceramides and sphingosine-1-phosphate, has been implicated in cardiovascular disease, although the specific species, disease contexts, and cellular roles are not completely understood. Sphingolipids are produced by the serine palmitoyltransferase enzyme, canonically composed of 2 subunits, SPTLC1 (serine palmitoyltransferase long chain base subunit 1) and SPTLC2 (serine palmitoyltransferase long chain base subunit 2). Noncanonical sphingolipids are produced by a more recently described subunit, SPTLC3 (serine palmitoyltransferase long chain base subunit 3). METHODS: The noncanonical (d16) and canonical (d18) sphingolipidome profiles in cardiac tissues of patients with end-stage ischemic cardiomyopathy and in mice with ischemic cardiomyopathy were analyzed by targeted lipidomics. Regulation of SPTLC3 by HIF1α under ischemic conditions was determined with chromatin immunoprecipitation. Transcriptomics, lipidomics, metabolomics, echocardiography, mitochondrial electron transport chain, mitochondrial membrane fluidity, and mitochondrial membrane potential were assessed in the cSPTLC3 KO transgenic mice we generated. Furthermore, morphological and functional studies were performed on cSPTLC3 KO mice subjected to permanent nonreperfused myocardial infarction. RESULTS: Herein, we report that SPTLC3 is induced in both human and mouse models of ischemic cardiomyopathy and leads to production of atypical sphingolipids bearing 16-carbon sphingoid bases, resulting in broad changes in cell sphingolipid composition. This induction is in part attributable to transcriptional regulation by HIF1α under ischemic conditions. Furthermore, cardiomyocyte-specific depletion of SPTLC3 in mice attenuates oxidative stress, fibrosis, and hypertrophy in chronic ischemia, and mice demonstrate improved cardiac function and increased survival along with increased ketone and glucose substrate metabolism utilization. Depletion of SPTLC3 mechanistically alters the membrane environment and subunit composition of mitochondrial complex I of the electron transport chain, decreasing its activity. CONCLUSIONS: Our findings suggest a novel essential role for SPTLC3 in electron transport chain function and a contribution to ischemic injury by regulating complex I activity.

Ceramide sensing by human SPT-ORMDL complex for establishing sphingolipid homeostasis

Mechanism of sphingolipid homeostasis revealed by structural analysis of Arabidopsis SPT-ORM1 complex

Structural insights into the assembly and substrate selectivity of human SPT–ORMDL3 complex

Structural insights into the regulation of human serine palmitoyltransferase complexes

The structure of the Orm2-containing serine palmitoyltransferase complex reveals distinct inhibitory potentials of yeast Orm proteins

The structure of the Orm2-containing serine palmitoyltransferase complex reveals distinct inhibitory potentials of yeast Orm proteins.

Cryo-EM Structure of Human Sphingomyelin Synthase and Its Mechanistic Implications for Sphingomyelin Synthesis

Mechanisms Involved in Cellular Ceramide Homeostasis

Involvement of a Cluster of Basic Amino Acids in Phosphorylation-Dependent Functional Repression of the Ceramide Transport Protein CERT

Unravelling neuronal and glial differences in ceramide composition, synthesis, and sensitivity to toxicity

Sphingolipid homeostasis--how do cells know when enough is enough? Implications for plant pathogen responses

Ciliogenesis Requires Sphingolipid-Dependent Membrane and Axoneme Interaction

Cardiomyocyte Specific Deficiency of Serine Palmitoyltransferase Subunit 2 Reduces Ceramide but Leads to Cardiac Dysfunction

The C10orf76-PI4KB axis orchestrates CERT-mediated ceramide trafficking to the distal Golgi

SPTLC3 Is Essential for Complex I Activity and Contributes to Ischemic Cardiomyopathy

The Ormdl genes regulate the sphingolipid synthesis pathway to ensure proper myelination and neurologic function in mice

Molecular Basis for the Catalytic Mechanism of Human Neutral Sphingomyelinases 1 (Hsmpd2).

Control of Mitochondria-Associated Endoplasmic Reticulum Membranes by Protein S-palmitoylation: Novel Therapeutic Targets for Neurodegenerative Diseases.

CDase Biochemical Characterization

Molecular machinery for non-vesicular trafficking of ceramide

Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis